Pharvaris N.V. Files March 2024 6-K Report

TL;DR

Pharvaris N.V. (PHVS) filed its March 6-K, standard reporting for foreign issuers.

AI Summary

Pharvaris N.V. filed a Form 6-K on March 6, 2024, to report its activities for the month of March 2024. The company, a pharmaceutical preparations firm based in Leiden, The Netherlands, is submitting this report under the Securities Exchange Act of 1934. Pharvaris N.V. previously operated under the name Pharvaris, B.V. before changing its name on October 29, 2020.

Why It Matters

This filing indicates ongoing reporting requirements for Pharvaris N.V. as a foreign private issuer, providing transparency to investors about its corporate activities.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate elevated risk.

Key Players & Entities

• Pharvaris N.V. (company) — Registrant
• 001-40010 (company) — SEC File Number
• 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
• Pharvaris, B.V. (company) — Former Company Name
• 20201029 (date) — Date of Name Change

FAQ

From the Filing

0000950170-24-027155.txt : 20240306 0000950170-24-027155.hdr.sgml : 20240306 20240306161502 ACCESSION NUMBER: 0000950170-24-027155 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 24726046 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 egm_2024.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of March 2024 Commission File Number: 001-40010 Pharvaris N.V. (Translation of registrant’s name into English) Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐   Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   PHARVARIS N.V.       Results of Extraordinary General Meeting of Shareholders   On March 6, 2024, Pharvaris N.V. (the “Company”) held an extraordinary general meeting of shareholders (the “EGM”). The final result of the agenda item submitted to a vote of the shareholders is as follows:   Agenda Item. Amendment to the Company's articles of association. The Company’s shareholders approved the amendment to the Company’s articles of association. A copy of the amended articles of association of the Company is attached hereto as Exhibit 3.1 and is incorporated herein by reference.                 SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.   PHARVARIS N.V.     Date: March 6, 2024 By: /s/ Berndt Modig   Name: Berndt Modig   Title: Chief Executive Officer   EXHIBIT INDEX   Exhibit No.   Description       3.1   Amended Articles of Association of Pharvaris